Charlottenlund, Denmark

Keld Dano Slashed


Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Keld Dano: Innovator in Cancer Research

Introduction

Keld Dano, an accomplished inventor based in Charlottenlund, Denmark, has made significant contributions to the field of cancer research through his innovative patents. With a total of three patents to his name, his work primarily focuses on antibodies and their applications in detecting and therapeutically targeting urokinase plasminogen activator receptors (u-PAR), a crucial player in cancer metastasis.

Latest Patents

Keld Dano's latest patents revolve around monoclonal and polyclonal antibodies directed against the urokinase plasminogen activator receptor. These antibodies are designed to react with free u-PAR or complexes involving u-PA and u-PAR, enabling various detection methods that include ELISA, blotting, and immunohistochemistry. His innovations also disclose methods for quantifying u-PAR levels and targeting diagnostics to cells expressing u-PAR, significantly enhancing the potential for early cancer detection and treatment. Additionally, Dano’s work includes the development of therapeutic agents aimed at preventing proteolytic activity in mammals, with practical applications in inhibiting cancer cell invasion and metastasis.

Career Highlights

Throughout his career, Keld Dano has been affiliated with notable organizations in the field of cancer research, including the Cancer Research Foundation of 1989. His expertise in immunology and oncology has positioned him as a leading figure in developing innovative methods for cancer detection and treatment.

Collaborations

Keld Dano has collaborated with other prominent researchers, including Vincent Ellis and Ebbe Rosenne, to progress the understanding of cancer biology and enhance the effectiveness of therapeutic strategies against cancer. These collaborations have fostered a rich environment for innovation and have led to significant advancements in the field.

Conclusion

Keld Dano’s contributions to cancer research through his innovative patents and collaborations underscore the importance of research in developing novel therapeutic agents. His work not only aids in understanding the complexities of cancer biology but also paves the way for improved diagnostic and treatment modalities, showcasing the vital intersection of science and innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…